Covered recipient · General Payments record
CHARLES MONTGOMERY
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
This page merges CMS profile IDs 11550670, 246270 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2018–2023
$7,345.86
- Reported across 475 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $918.40 | 48 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $75.88 | 4 |
| Merck Sharp & Dohme Corporation | $69.23 | 3 |
| Gilead Sciences, Inc. | $65.48 | 3 |
| CTI BioPharma Corp. | $58.94 | 3 |
| Incyte Corporation | $53.02 | 3 |
| SEAGEN INC. | $51.39 | 3 |
| Pharmacyclics LLC, An AbbVie Company | $47.83 | 3 |
| Lilly USA, LLC | $45.17 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.62 | 2 |
| Kite Pharma, Inc. | $31.27 | 2 |
| EISAI INC. | $30.94 | 2 |
| Deciphera Pharmaceuticals Inc. | $30.52 | 1 |
| Mirati Therapeutics, Inc. | $30.34 | 2 |
| Foundation Medicine, Inc. | $30.25 | 1 |
| TerSera Therapeutics LLC | $28.92 | 1 |
| Sumitomo Pharma America, Inc. | $25.13 | 1 |
| Stemline Therapeutics Inc. | $23.20 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.34 | 1 |
| BeiGene USA, Inc. | $20.23 | 1 |
| Genentech USA, Inc. | $19.27 | 1 |
| Astellas Pharma US Inc | $17.82 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.23 | 1 |
| ABBVIE INC. | $17.03 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.44 | 1 |
| Amgen Inc. | $15.59 | 1 |
| PFIZER INC. | $15.48 | 1 |
| GlaxoSmithKline, LLC. | $15.35 | 1 |
| Janssen Biotech, Inc. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (48)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
- Merged CMS profile IDs
- 11550670, 246270
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.